CareDx, Inc. (CDNA) Stock: Dividends & Earnings

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $13.95 - $65.64

10 Year CDNA Performance Metrics:

Total Return (with DRIP): 1,633% (33.01% CAGR)

Total Return (no DRIP): 1,633% (33.01% CAGR)

Share Price: 1,633% (33.01% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $173,333

Total Return $ (with DRIP): $163,333

CDNA Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

CDNA Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for CDNA

Based on past 10-year performance, here are CDNA growth metrics:

Share price CAGR of +33.74%
Dividend CAGR of +0%

Using CDNA CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	CDNA (DRIP)	CDNA - No DRIP
Current Price	$65.00	$65.00
Start Shares	153.85	153.85
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	153.85	153.85
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$65.00	$65.00
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - CDNA

NOTE: Above numbers are our estimate based on CDNA's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

CareDx, Inc. (CDNA) had its IPO on , and is traded on NASDAQ stock exchange.

CareDx, Inc. is a precision medicine diagnostics company focused on transplant care and related specialty services. CareDx develops and commercializes non-invasive molecular tests, laboratory products, digital tools, and patient support services that help clinicians monitor organ health before and after transplantation. Its portfolio includes testing solutions for kidney, heart, and lung transplant patients, along with HLA typing and other transplant laboratory products used to support donor-recipient matching and post-transplant surveillance. The company also offers workflow software, data analytics, and care-management tools that connect transplant centers, patients, and providers across the care journey. In addition to its core transplant business, CareDx serves specialty oncology and cell therapy markets with precision diagnostics and support solutions. CareDx, Inc. is headquartered in Brisbane, California.

CDNA website: https://caredx.com